Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT studyCatto, J W F; Robinson, M C; Albertsen, P C; Goepel, J R; Abbod, M F; Linkens, D A; Davis, M; Rosario, D J; Warren, A Y; Varma, M; Griffiths, D F; Grigor, K M; Mayer, N J; Oxley, J D; Deshmukh, N S; Lane, J A; Metcalfe, C; Donovan, J L; Neal, D E; Hamdy, F C · British Journal of Cancer · 2011

Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy resultMacefield, R C; Metcalfe, C; Lane, J A; Donovan, J L; Avery, K N L; Blazeby, J M; Down, L; Neal, D E; Hamdy, F C; Vedhara, K · 2010

135 Psychological impact of PSA testing and biopsy using the impact of event scaleKok, E.T.; Turner, E.L.; Davis, M.J.; Metcalfe, C.; Lane, J.A.; Neal, D.E.; Hamdy, F.C.; Donovan, J.L. · European Urology Supplements · 2013

Design and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)Turner, E L; Metcalfe, C; Donovan, J L; Noble, S; Sterne, J A C; Lane, J A; Avery, K N; Down, L; Walsh, E; Davis, M; Ben-Shlomo, Y; Oliver, S E; Evans, S; Brindle, P; Williams, N J; Hughes, L J; Hill, E M; Davies, C; Ng, S Y; Neal, D E; Hamdy, F C; Martin, R M · British Journal of Cancer · 2014

Current strategies for monitoring men with localised prostate cancer lack a strong evidence base: observational longitudinal studyNeal, D E; Metcalfe, C; Tilling, K; Davis, M; Lane, J A; Martin, R M; Kynaston, H; Powell, P; Hamdy, F; Donovan, J L · 2009

Low risk research using routinely collected identifiable health information without informed consent: encounters with the Patient Information Advisory GroupMetcalfe, C; Martin, R M; Noble, S; Lane, J A; Hamdy, F C; Neal, D E; Donovan, J L · Journal of Medical Ethics · 2008

Association of Folate-Pathway Gene Polymorphisms with the Risk of Prostate Cancer: a Population-Based Nested Case-Control Study, Systematic Review, and Meta-analysisCollin, S. M.; Metcalfe, C.; Zuccolo, L.; Lewis, S. J.; Chen, L.; Cox, A.; Davis, M.; Lane, J. A.; Donovan, J.; Smith, G. D.; Neal, D. E.; Hamdy, F. C.; Gudmundsson, J.; Sulem, P.; Rafnar, T.; Benediktsdottir, K. R.; Eeles, R. A.; Guy, M.; Kote-Jarai, Z.; Morrison, J.; Al Olama, A. A.; Stefansson, K.; Easton, D. F.; Martin, R. M. · Cancer Epidemiology Biomarkers & Prevention · 2009

Evolving treatment strategies for myelomaMorgan, G J; Davies, F E · British Journal of Cancer · 2005

Exploiting nanotechnology to target cancerSengupta, S; Sasisekharan, R · British Journal of Cancer · 2007

Selection of controlsvon Euler-Chelpin, M; Lynge, E · British Journal of Cancer · 2007

The Treatment of Retinal GliomaJapha, E M · British Journal of Cancer · 1949

Author IndexBritish Journal of Cancer · 1947

Screening Tests in Chemical CarcinogenesisFox, M · British Journal of Cancer · 1976

Fundamentals of Cancer ChemotherapyBush, H · British Journal of Cancer · 1979

Tumour Markers: impact and ProspectsCoombes, R C · British Journal of Cancer · 1980